Cited 0 times in Scipus Cited Count

Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer

Cho, O  | Chun, M  | Chang, SJ  | Oh, YT  | Noh, OK
Anticancer research, 36(7). : 3541-3547, 2016
Journal Title
Anticancer research
AIM: To investigate whether common terminology criteria for adverse events (CTCAE) grade 4 lymphopenia (<200 cells/mul) during concurrent chemoradiotherapy (CCRT) is relevant to poor survival. PATIENTS AND METHODS: We analyzed 124 patients with newly diagnosed Federation of Gynecology and Obstetrics (FIGO) stage I-III cervical cancer who received weekly cisplatin-based CCRT and brachytherapy using Kaplan-Meier curves and the Cox proportional hazard models. RESULTS: Grade 4 lymphopenia significantly predicted disease-specific survival (DSS) and progression-free survival (PFS) (adjusted hazard ratio (95% confidence interval (CI))=3.6 (1.37-9.44), p=0.009 and 3.28 (1.27-8.48), p=0.014, respectively). The 5-year DSS and 3-year PFS were significantly higher among patients with grade 2-3 lymphopenia (>/=200 cells/mul) than among those with grade 4 lymphopenia (84.8% vs. 50.4%, p<0.001, and 80.7% vs. 50%, p=0.002, respectively). CONCLUSION: Severe lymphopenia during CCRT could predict poor survival.

Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiation Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Obstetrics & Gynecology
Ajou Authors
노, 오규  |  오, 영택  |  장, 석준  |  전, 미선  |  조, 오연
Full Text Link
Files in This Item:
There are no files associated with this item.


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.